Organization | Federal University of Rio Grande do Sul

Federal University of Rio Grande do Sul Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Porto Alegre Rio Grande do Sul Brazil (1934)

Organization Overview

First Clinical Trial

1997

NCT01039818

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Agnes Nogueira Gossenheimer | Aline Nogueira Haas | Brain Institute of Rio Grande do Sul | Denusa Wiltgen | Director, School of Medicine, PUCRS, Brazil; Brain Instititute of Rio Grande do Sul, Brazil | Federal University of Rio Grande do Sul | Federal University of Rio Grande do Sul - Brazil | Federal University of Rio Grande do Sul - Faculty of Medicine | Federal University of Rio Grande do Sul, Porto Alegre, Brazil | Federal University of Rio Grande do Sul (UFRGS) | Federal University of Rio Grande do Sul (UFRGS) / Hospital de Clinicas de Porto Alegre | Federal Universty of Rio Grande do Sul | Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil | Hospita de ClÃnicas de Porto Alegre | Hospital de ClÃnicas de Porto Alegre | Hospital de ClÃnics de Porto Alegre | Hospital de Clinicas de Porto Alegre and UFRGS | Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil | Hospital de Clinicas de Porto Alegre, Servico de Genetica Medica | Hospital de Clinicas de Porto Alegre - UFRGS | Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul | Hospitall de ClÃnicas de Porto Alegre | Hosptital de ClÃnicas de Porto Alegre | Instituto de Cardiologia do Rio Grande do Sul | Instituto de Cardiologia / Fundação Universitária de Cardiologia | Medical Genetics Service Hospital de Clinicas de Porto Alegre | Pedro Lopez da Cruz | silvia goldmeier | TelessaúdeRS / UFRGS | UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL | UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL (UFRGS)

Active Ingredients

Drugs in Phase 4 Trials (45)

acetylcysteine (mucomyst) (3 trials)

acetylsalicylic acid (aspirin) (1 trial)

aripiprazole (abilify) (2 trials)

azithromycin (zithromax) (1 trial)

captopril (capoten) (1 trial)

carbamazepine (tegretol) (1 trial)

clindamycin (cleocin) (1 trial)

clozapine (clozaril) (1 trial)

cocaine (Erythroxyline) (1 trial)

doxycycline (vibramycin) (2 trials)

ethanol (2 trials)

everolimus (zortress) (1 trial)

ezetimibe (zetia) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

glyburide (micronase) (2 trials)

heparin (liquaemin) (2 trials)

hydroxychloroquine (plaquenil) (1 trial)

idursulfase (elaprase) (3 trials)

ketamine (ketalar) (3 trials)

lithium (lithonate) (6 trials)

memantine (namenda) (1 trial)

menopausal gonadotropin (1 trial)

methadone (methadose) (1 trial)

methylphenidate (ritalin) (4 trials)

metronidazole (flagyl) (3 trials)

misoprostol (cytotec) (2 trials)

nitric acid (1 trial)

nortriptyline (aventyl) (3 trials)

olanzapine (zyprexa) (2 trials)

ornithine aspartate (1 trial)

protamine sulfate (1 trial)

quetiapine (seroquel) (2 trials)

resveratrol (2 trials)

rhodiola (2 trials)

risperidone (risperdal) (5 trials)

sertraline (zoloft) (4 trials)

simvastatin (zocor) (1 trial)

sitagliptin (januvia) (3 trials)

spironolactone (aldactone) (1 trial)

tacrolimus (prograf) (1 trial)

taurolidine (Defencath) (1 trial)

topiramate (topamax) (1 trial)

valproic acid (depakene) (2 trials)

vildagliptin (1 trial)

vitamin d3 (5 trials)

Drugs in Phase 3 Trials (43)

125-iodine (1 trial)

acetaminophen (tylenol) (3 trials)

aluminum hydroxide (Gaviscon) (2 trials)

amantadine (symmetrel) (1 trial)

amiloride (midamor) (5 trials)

amitriptyline (elavil) (2 trials)

amlodipine (norvasc) (1 trial)

apple (1 trial)

arginine (1 trial)

autologous microbiome (1 trial)

cannabidiol (Epidiolex) (1 trial)

cefepime (maxipeme) (1 trial)

chlorhexidine (hibitane) (1 trial)

chlorpheniramine (ChlorTrimeton) (2 trials)

chlorthalidone (Hygroton) (4 trials)

clarithromycin (biaxin) (1 trial)

clomifene (clomid) (1 trial)

COVID-19 convalescent plasma (1 trial)

danegaptide (1 trial)

epoetin (Epogen) (1 trial)

ferrous sulfate (1 trial)

furosemide (lasix) (2 trials)

hydrochlorothiazide (esidrix) (1 trial)

imiquimod (aldara) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

iron dextran (INFeD) (1 trial)

leucovorin (2 trials)

losartan (cozaar) (1 trial)

melatonin (2 trials)

naltrexone (revia) (2 trials)

omeprazole (prilosec) (1 trial)

panthenol (1 trial)

pregabalin (lyrica) (2 trials)

procaine benzylpenicillin (novocaine) (1 trial)

raloxifene (evista) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

sulpiride (2 trials)

testosterone (delatestryl) (1 trial)

tianeptine (Stablon) (1 trial)

verapamil (calan) (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

Drugs in Phase 2 Trials (19)

albumin (Human) (Plasbumin) (1 trial)

allogeneic natural killer cells (1 trial)

alteplase (Activase) (1 trial)

atorvastatin (lipitor) (1 trial)

autologous mesenchymal stem cells (1 trial)

autologous natural killer cells (1 trial)

conjugated equine estrogens (Premarin) (1 trial)

cytarabine (cytosar-u) (1 trial)

enalapril (vasotec) (2 trials)

fludarabine (fludara) (1 trial)

forodesine (1 trial)

l-epigallocatechin (1 trial)

letrozole (femara) (1 trial)

oat bran (1 trial)

remifentanil (ultiva) (1 trial)

riboflavin (1 trial)

sargramostim (leukine) (1 trial)

sildenafil (viagra) (1 trial)

sodium phenylbutyrate (buphenyl) (1 trial)

Drugs in Phase 1 Trials (3)

angiotensin 1-7 (1 trial)

eggplant (1 trial)

sodium fluoride (18F) (1 trial)

Drugs in Other Trials (46)

bupropion (wellbutrin) (1 trial)

caffeine (1 trial)

citalopram (celexa) (1 trial)

clomipramine (anafranil) (1 trial)

codeine (Phenergan) (1 trial)

doxazosin (cardura) (1 trial)

drospirenone (Yasmin) (1 trial)

duloxetine (Cymbalta) (1 trial)

escitalopram (lexapro) (1 trial)

esmolol (brevibloc) (1 trial)

estradiol (progynon depot) (2 trials)

ethinyl estradiol (Estinyl) (1 trial)

fluoxetine (prozac) (2 trials)

fluvoxamine (luvox) (1 trial)

fructose (1 trial)

gestodene (Femodene) (1 trial)

glucose (1 trial)

glucose monohydrate (1 trial)

guar gum (1 trial)

icosapent ethyl (vascepa) (2 trials)

imipramine (tofranil) (1 trial)

insulin human (humulin) (1 trial)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (1 trial)

levobupivacaine (chirocaine) (1 trial)

levothyroxine (Synthroid) (1 trial)

mirtazapine (remeron) (1 trial)

nevulose (1 trial)

nitroprusside (nipride) (1 trial)

norepinephrine (levophed) (1 trial)

olive (1 trial)

paroxetine (paxil) (1 trial)

progesterone (progestasert) (2 trials)

prostaglandin (1 trial)

pyridostigmine bromide (mestinon) (1 trial)

resistant starch (1 trial)

sodium chloride (1 trial)

sofosbuvir (sovaldi) (1 trial)

soybean (1 trial)

theobroma cacao whole (1 trial)

tramadol (Ultram) (1 trial)

tranylcypromine (parnate) (1 trial)

trazodone (desyrel) (1 trial)

triamcinolone (kenalog) (1 trial)

velpatasvir (Epclusa) (1 trial)

venlafaxine (effexor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Abortion, Septic (Phase 4)

Abortion, Spontaneous (Phase 4)

Acute Pain (Phase 3)

Alcoholism (Phase 4)

Anemia (Phase 3)

Anemia, Sickle Cell (Phase 3)

Aneurysm (Phase 2)

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Apnea (Phase 4)

Arthralgia (Phase 2)

Ataxia (Phase 3)

Atherosclerosis (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Behavior, Addictive (Phase 4)

Bipolar Disorder (Phase 4)

Brain Diseases (Phase 4)

Bronchopulmonary Dysplasia (Phase 4)

Carcinoma (Phase 3)

Cardiovascular Diseases (Phase 4)

Catheter-Related Infections (Phase 4)

Cerebellar Ataxia (Phase 3)

Cheilitis (Phase 3)

Chronic Pain (Phase 2)

Cocaine-Related Disorders (Phase 4)

Coinfection (Phase 3)

Common Cold (Phase 3)

Communicable Diseases (Phase 4)

Constipation (Phase 3)

Coronary Artery Disease (Phase 4)

Critical Illness (Phase 3)

Cross Infection (Phase 3)

Dental Plaque (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetes, Gestational (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Digestive System Diseases (Phase 3)

Dilatation, Pathologic (Phase 4)

Disease (Phase 4)

Dyslipidemias (Phase 3)

Dyspepsia (Phase 3)

Eclampsia (Phase 3)

Endometriosis (Phase 4)

Essential Hypertension (Phase 3)

Euthyroid Sick Syndromes (Phase 4)

Fibromyalgia (Phase 3)

Graft vs Host Disease (Phase 2)

Graves Disease (Phase 3)

Heart Diseases (Phase 4)

Heart Failure (Phase 3)

HELLP Syndrome (Phase 3)

Hemorrhage (Phase 2)

Hemorrhoids (Phase 3)

Hepatic Encephalopathy (Phase 4)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Hepatitis, Chronic (Phase 3)

Homocystinuria (Phase 2)

Hot Flashes (Phase 3)

Hyperandrogenism (Phase 4)

Hypercholesterolemia (Phase 2)

Hyperkinesis (Phase 4)

Hypertension (Phase 4)

Hyperthyroidism (Phase 3)

Infarction (Phase 4)

Infections (Phase 4)

Infertility (Phase 4)

Inflammation (Phase 3)

Influenza, Human (Phase 3)

Intracranial Aneurysm (Phase 2)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lymphoma (Phase 2)

Machado-Joseph Disease (Phase 3)

Mood Disorders (Phase 4)

Mucopolysaccharidoses (Phase 4)

Mucopolysaccharidosis II (Phase 4)

Muscle Spasticity (Phase 3)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Myofascial Pain Syndromes (Phase 3)

Neuralgia (Phase 4)

Obesity (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Polyneuropathies (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Pre-Eclampsia (Phase 3)

Prehypertension (Phase 3)

Renal Insufficiency (Phase 2)

Respiratory Tract Diseases (Phase 3)

Respiratory Tract Infections (Phase 3)

Root Caries (Phase 1)

Rupture (Phase 2)

Schizophrenia (Phase 4)

Sepsis (Phase 2)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Spinocerebellar Ataxias (Phase 3)

Spinocerebellar Degenerations (Phase 3)

ST Elevation Myocardial Infarction (Phase 2)

Stroke (Phase 2)

Subarachnoid Hemorrhage (Phase 2)

Substance-Related Disorders (Phase 4)

Syndrome (Phase 4)

Urinary Tract Infections (Phase 3)

Vasospasm, Intracranial (Phase 2)

Vitamin D Deficiency (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 139
# of Trial APIs: 156